Well, I'm afraid I don't see the urgency. I see the importance of the issue, but I don't see the urgency. As Mr. Webber has now clarified, this motion doesn't have anything to do with organ transplants. It's about blood donation.
I could make the same argument. We're in the middle of a pharmacare study. I would venture to guess that there are Canadians who are dying, probably this week, because they don't have access to their medication.
We've had testimony already about the effect of cost-related non-adherence, and there are Canadians who get seriously ill because they don't have access to their pharmacare. That's a pressing problem right now.
Quite honestly, the Conservatives were in power for 10 years and never touched this issue once. Frankly, the current government had a chance to look at this and moved from a five-year ban on men having sex with men with regard to blood donations to one year.
This is an important issue. I don't think it's urgent. I think we should be looking at it. Even if we study this issue, say a month from now, and we devote a meeting—which, by the way, I don't think a meeting is enough for this. I think if we want to have a science-based, evidence-based look at this, we're going to have to hear from a number of experts in this field: hematologists and otherwise, Canadian Blood Services.
I haven't heard whether we're going to write a report or not, which we would probably have to do if you want to have an impact with the minister. You're talking about multiple meetings, unless we just want to make a political issue out of this and have a pro forma meeting.
If we want to take a real look at whether there's a basis for this issue, we should treat it with the seriousness it deserves. It would probably need three or four meetings, I would say, to look at that issue.
If we do that, then we're pushing our pharmacare study back significantly. I'm not so sure, when you weigh the competing importance, that there's any real way to differentiate between them. As important as the ban on men having sex with men issue is, again, I think so is pharmacare.
I would urge that we pass the motion, but I'm not so sure that we need to schedule hearings on this until after the pharmacare study.